The Angioshield Study Feasibility II

NCT02543047 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Angioshield

Sponsor

Neograft Technologies, Incorporated